SYNTHESIS AND NOVEL SALT FORMS OF (R)-5-((E)-2-PYRROLIDIN-3-YLVINYL)PYRIMIDINE

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20230295126A1
SERIAL NO

18061354

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the stereospecific synthesis of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine, its salt forms, and novel polymorphic forms of these salts.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
OYSTER POINT PHARMA INCPRINCETON NJ

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
AKIREDDY, Srinivasa Rao Winston-Salem, US 25 81
BHATTI, Balwinder Singh Winston-Salem, US 51 330
CUTHBERTSON, Timothy J Winston-Salem, US 13 57
Dull, Gary Maurice Winston-Salem, US 75 743
MILLER, Graig Harrison Winston-Salem, US 1 0
MITCHENER, Joseph Pike Winston-Salem, US 6 15
MUNOZ, Julio A Walnut Cove, US 34 269
OTTEN, Pieter Albert King, US 11 47

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation